Evening of Art + Science a rousing success!
On a glorious spring evening in Detroit, the worlds of medical research and artistic endeavor met at the Museum of Contemporary Art Detroit (MOCAD) to showcase the results of a unique collaboration between Taubman Institute scientists and some of today's most bold and talented artists.
Dozens of art enthusiasts and supporters of medical science turned out to meet, mingle, dine and to admire the amazing creations which were auctioned to benefit the medical research supported by the institute.
Camaraderie, cuisine, creativity and cocktails reigned throughout this delightful event.
And the proceeds will allow us to expand the ranks of our innovative Taubman Emerging Scholars Program, which ensures the next generation of extraordinary young clinician-scientists won’t be lost to research for lack of funding.
Our deepest thanks to everyone who participated, contributed, created and partied to help make the Evening of Art + Science a wonderfully successful project.
Together, we are making a difference.
Dr. Eva Feldman: Alfred Taubman as mentor, leader, friend
The source of his greatness lay in his willingness to challenge conventional thinking.
Emerging Scholars Symposium set for April 29
Annual showcase of early career physician-researchers runs 10 a.m. to noon at the A. Alfred Taubman Biomedical Science Research Building.
Dr. Max Wicha receives $6.5 million to target cancer stem cells
The award from the National Cancer Institute will fuel research into the cells that cause metastasis.
news & events
In the News
Taubman Emerging Scholar partners in ACL repair study
Asheesh Bedi, M.D., is an investigator in a study using human growth hormone to aid healing of the common knee injury.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D. and team find a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Arthritis drug may help diabetics with kidney disease
Research led by Taubman Scholar Frank Brosius has led to a fast-track study that shows promising results